Form D · Pharmaceuticals
Pharmabiotix Inc
Dallas, TX · CIK 0001399198
Offering snapshot reported Dec 30, 2014 · SEC filing
- Reported sold
- $256K Offering amount: $500K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Dec 30, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2014 | Initial | $256,000 | No comparison | 4 | SEC filing |
| Apr 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-231127
Source: Form D, filed Dec 30, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John P. Bennett | Director, Executive |
| Mark Cobb | Director, Executive |
| Alyson Cobb | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
7114 Casa Loma Avenue
Dallas, TX, 75214
Dallas, TX, 75214